WO

Will Olsen

Founder of Engage Bio

Menlo Park, California

Overview

Work Experience

EB

Engage Bio

  • Co-Founder & CEO

    2021 - Current

    Engage Bio is developing Tethosomes, the next generation of non-viral DNA medicines. Tethosomes are highly potent, non-immunogenic, redosable, and titratable. At Engage, we're focused on building genetic medicines that scale. www.engagebio.com

PF

Pioneer Fund

  • Venture Partner

    2019

RT

Rejuvenation Technologies Inc.

  • Vice President of Development Operations

    2019 - 2021

    Developing TERT mRNA therapy to extend telomeres and increase the human healthspan.

L(

Luminist (Acquired by DiscernDx)

  • Co-founder and Chief Operating Officer

    2015 - 2020

    Diagnostic platform for early detection of liver disease. Acquired by diagnostic developer DiscernDx.

B

Biorasi

  • Senior Program Manager

    2015 - 2015

    Designed and managed early-phase clinical programs. Participated in business development, including bid defenses and acting as technical sales lead.

  • Program Manager

    2013 - 2015

MS

Mount Sinai Health System

  • Research Associate

    2012 - 2013

SE

SpaceWorks Enterprises, Inc. (SEI)

  • Economic Analyst Intern

    2010 - 2010

Education

Investments

Granza Bio

Seed

Total Funding: $7.5M

Relevant Websites